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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S262Methods: A convenience sample of 28 individuals was studied. All
participants had to be 40 yr of age and meet the ACR deﬁnition for
knee OA. There was no requirement for minimum pain intensity and
management was to be continued as required. All participants were
asked to response to pings prompted from their smart phones and
subsequently rate their knee pain (0: no pain, 10: worst possible) three
times per day over 3months. Each of three daily pings was programmed
to occur at random in each of three 4-hour blocks (8am-noon, noon-
4pm, and 4pm-8pm). To characterize the statistical properties of the
time series of pain ratings, the means of the pain ratings in three blocks
were calculated and compared by one way analysis of covariance. As
well, fractal dimension, D, was calculated using rescaled range analysis
to characterize the OA participants’ pain ﬂuctuations.
Results: Thirty-two individuals participated in the study (18 females,
age (mean, standard deviation) 59.7 6.5 yr; 10 males, 55.36.7 yr). As
shown in Figure A, there is no signiﬁcant difference among the three
blocks of time for the mean rating of pain. Figure B displays the
distribution of fractal dimension, D. calculated for each individual's
mean daily pain intensity. The mean fractal dimension, D, for the
population is 1.650.04, which signiﬁes an anti- persistent pain time
series.
Conclusions: This is the ﬁrst analysis to characterize the fractal
dimension of OA pain. The ﬁnding of anti-persistent time series means
that on average more intense pain is followed by lesser pain, a ﬁnding
very similar to that reported for chronic low back pain and in contrast to
both purely neuropathic pain and acute pain. Whereas these previous
studies were over short time periods, this study suggests that power
law scaling can be preserved for much longer periods of time (weeks or
months), which is signiﬁcant for clinical application. The anti-persistent
pattern of pain is consistent with the concept of central pain processes
activated to modulate peripheral pain input in OA.
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THE SOURCES OF PAIN IN KNEE OSTEOARTHRITIS ARE CHANGING
DEPENDENT UPON THE PROGRESSION OF THE DISEASE
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Purpose: Pain is the most prominent and disabling symptom of oste-
oarthritis (OA). Thus, it is important to understand the cause of pain to
optimally treat this common disease. Pain in knee OA is involved in
a nociceptive pain, of which inﬂammation and the detrimental
mechanical stress to the joint are main cause. Recent studies have
shown that OA is associated with the signs and symptoms of inﬂam-
mation, and synovitis is common in OA. Serum levels of interleukin-6
(IL-6) and C-reactive protein (CRP) are reported to be associated with
synovitis and pain severity in knee OA. Walking analysis showed that
pain induced by detrimental mechanical stress due to the knee defor-
mity was positively correlated with pain severity only in advanced stage
of knee OA. However, it's still remained unclear which of these two
factors dominantly contribute to knee OA pain, or do their contributions
to knee OA pain may change according to the OA severity? This studywas conducted to answer these questions by obtaining data from knee
OA patients.
Methods: In this prospective cohort study, one-hundred sixty post-
menopausal women with knee OA, who had complained of knee pain
and provided written informed consent, were enrolled between Oct.
2009 and Dec. 2011. The severity of knee OA was classiﬁed by Kellgren-
Lawrence (K/L) grading scale based on standing extended-knee X-ray
images. Pain was evaluated by a visual analogue scale (VAS, 0-100) and
pain and stiffness sub-category of Japanese Knee Osteoarthritis
Measure (JKOM-pain), which is a patient-oriented outcomemeasure for
knee OA with sufﬁcient reliability and validity, similar to WOMAC and
SF-36. Serum levels of IL-6 and CRP were measured to monitor the
inﬂammation of knee OA. Anatomical axis angle (AAA) on standing
radiograph was measured as the objective indicator for mechanical
stress for lower limb. Univariate and multivariate analyses were con-
ducted to examine the relationships between the pain severities and
several clinical manifestations of knee OA patients.
Results:When a univariate analysis was conducted in all patients, there
was no signiﬁcant correlation between pain scores (pain VAS and
JKOM-pain) and the baseline characteristics, serum levels of IL-6 and
CRP, and radiographic OA severity, including in AAA. When the patients
were divided into two groups according to the radiographic severity of
knee OA, the early- (K/L2;67) and advanced-stage (K/L3 and 4; 93),
there was signiﬁcant positive correlation between serum IL-6 level and
both pain VAS score (r¼0.411, p¼0.001) and JKOM-pain score (r¼0.526,
p<0.001) in the early stage, while in advanced stage no signiﬁcant
correlations were found between these parameters. On the other hand,
there was signiﬁcant positive correlation between AAA and both pain
VAS score (r¼0.224, p¼0.033) and JKOM-pain score (r¼0.298, p¼0.004)
in the advanced stage, while in early stage no signiﬁcant correlations
were found between these parameters. Next, a multivariate analysis
was conducted to ﬁnd out the factors those can explain the pain severity
by loading of age, BMI, serum IL-6 level, serum hs-CRP level and AAA.
No factors were found to explain the pain severity when all patients
were included in the analysis. However, when the analysis was con-
ducted to the patients in early stage, only serum IL-6 level was signif-
icantly correlated with both the JKOM-pain score (b¼0.566,p<0.001)
and pain VAS score (b¼0.411,p¼0.002). When the analysis was con-
ducted to the patients in advanced stage, only AAA was signiﬁcantly
correlated with both the JKOM-pain score (b¼0.330, p¼0.004) and pain
VAS score (b¼0.240, p¼0.037).
Conclusions: The present study suggests that the components of knee
OA pain are changing dependent upon the progression of the disease;
the pain severity in knee OA patients is mainly affected by inﬂamma-
tion, probably synovitis, in early stage, while that of those by detri-
mental mechanical stress in advanced stage.
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EXPLORATORY EVALUATION OF A TREADMILL WALKING MODEL TO
ASSESS TREATMENT-RELATED ANALGESIA IN SUBJECTS WITH
OSTEOARTHRITIS KNEE PAIN
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Purpose: Sensitive, relevant and reliable measurements of pain levels
and their relationship to physical function are important for the
development of novel therapeutics for knee osteoarthritis (KOA). We
modiﬁed a previously-reported treadmill walking test protocol and
explored its capacity to measure analgesic efﬁcacy at baseline and
during paced walking. We hypothesized this would facilitate subject
enrollment and provide direct static and dynamic assessments of KOA
pain intensity and a response to acute treatment with conventional
doses of naproxen.
Methods: This was a randomized, double-blind, 3-period crossover
study performed at one site. Subjects with documented KOA were
screened to conﬁrm that their pain intensity (PI) scores were > 1 point
higher on an 11 point NRS scale after two weeks withdrawal of their
regularly prescribed NSAID. They thenwere randomized (1:1) to receive
different sequences of three 4-day courses of blinded capsules of BID
doses of 500mg naproxen (N) or placebo (P): N-P-P or P-N-N with 4 day
inter-period washouts. At each visit, the treadmill walking protocol
required four 20-min walks with 40 min rest periods. Subjects had one
predetermined self-paced (SP) walk prior to dosing on Day 4, then took
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a series of two additional SP walks followed by a high paced (HP) walk,
at 30% faster pace than their SP walk. Prior to (t ¼ 0) and every 3
minutes after each walk initiation the subjects were queried for their
current KOA PI score. Primary endpoint time weighted average pain
scores on the treadmill (TWAP), used to estimate differences in average
pain scores (APS) between P and N treatments. Secondary endpoints:
included changes in WOMAC 3.1 VAS scores, Investigator Global
Assessment of Disease Status (IGADS) and adverse events (AEs). Other
assessments included surface joint temperature and algometry. Statis-
tical analyses included a mixed effect model with ﬁxed effects for
period and treatment and random effect for subject with carryover
investigated in a sensitivity analysis. For the analysis of WOMAC scores
the pre-treatment baselines recorded in each period were included as
two covariates representing the individual's average baseline and the
difference from this average.
Results: In randomized KOA subjects (N¼23), there were signiﬁcant
treatment effects during naproxen treatment vs placebo treatment at t
¼ 0 and during the treadmill walk, noted in APS by TWAP andWOMAC.
The most sensitive endpoints, were t¼0 values (N vs P: APS -0.93(CI:
-1.52, -0.34), p¼0.004, on 3rd SP walk. Increased effect size by TWAP
was seen in the HP walks (N vs P: -1.02; (CI: -1.61, -0.43), p¼0.002).
WOMAC Pain scores at the start of the study were 53.4 (sd 15.8). Total
WOMAC and all subscale scores showed signiﬁcant differences between
naproxen and placebo. The treadmill walking scores maintained the
APS treatment differences but did not capture additional (dynamic)
analgesic signals. IGADS scores also reﬂected treatment differences.
Conclusions: The modiﬁed walking model showed pain intensity
differences between treatments at t¼0 and during treadmill in a rela-
tively small KOA population. The modiﬁcations expedited enrollment
and time to completion but limited interpretation of pain on walking.
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PREDICTORS FOR THE PROGRESSION OF KNEE PAIN IN SUBJECTS
WITH EARLY SYMPTOMATIC KNEE OSTEOARTHRITIS - FIVE YEAR
RESULTS FROM THE CHECK STUDY
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Purpose: To determine which patient- or disease characteristics can
help predict future pain trajectories in patients with early symptomatic
osteoarthritis of the knee (knee OA).
Methods: The data were acquired from the Cohort Hip and Cohort Knee
(CHECK) study, a prospective follow-up cohort of 1002 participants
with early symptomatic knee and/or hip OA. We restricted ourselves to
participants who had knee pain; knee OA according to the ACR criteria;
and a completed follow-up period. Baseline characteristics were
assessed. The outcome measure was pain assessed by the Visual
Analogue Score (VAS) over a ﬁve year period. The participants were
categorized into three distinct pain trajectories retrieved by latent class
growth analysis. This resulted in a favourable; a stable; and an unfav-
ourable course of pain group. Multinomial logistic regression analyses
were performed univariately and multivariately to calculate odds ratios
(ORs) and corresponding 95% conﬁdence intervals (95% CI) in order to
estimate the association of baseline variables with the distinct trajec-
tories. Additionally a subanalysis was performed for smaller subgroups
with more extreme courses of pain.
Results: 705 participants were included in our analyses (¼ 705 knees).
Therewere signiﬁcant differences between the pain trajectory groups in
how participants cope with pain. Four variables remained statistically
signiﬁcant after the univariate and the multivariable analyses between
the unfavourable and the favourable course of pain group: number of co
morbidities (> 1 vs.  1) (OR 2.2 [1.2-4.1]); baseline VAS (OR 1.8 [1.5-
2.1]); pain during active ﬂexion of the knee (yes vs. no) (OR 2.2 [1.0-
4.5]); and joint space tenderness of the index knee during physical
examination (yes vs. no) (OR 2.1 [1.1-3.8]). The subanalysis showed
similar signiﬁcant variables.
Conclusions: Individuals with early symptomatic knee OAwho present
with more severe joint pain; lesser capability to cope with pain; multi
morbidity; joint space tenderness of the index knee; pain in the ipsi-
lateral hip; and painful range of motion of the ipsilateral hip have an
increased risk of progression of knee pain during a ﬁve year follow-up
period.509
INVESTIGATION OF THE RELATIONSHIP BETWEEN HIP BONE
MARROW LESIONS, HIGH CARTILAGE SIGNAL AND HIP AND KNEE
PAIN IN TWO POPULATION-BASED COHORTS
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Aim: To examine the relationship between hip BMLs, high cartilage
signal and hip and knee pain using data from two geographically
different cohorts.
Methods: The ﬁrst cohort included 143 healthy subjects from the
Melbourne Collaborative Cohort study (MCCS) with a right hip MRI
conducted during 2009-2010. The second cohort involved 198 subjects
from Tasmanian Older Adult Cohort (TASOAC) with right hip MRI con-
ducted at two time points, approx. 2.6 years apart. Subjects inMCCS had
a T2-weighted MRI sequence and those in TASOAC had a Short T1
Inversion Recovery (STIR) MRI sequence. These MRI images were used
to quantitatively assess hip BMLs size and determine high cartilage
signal presence. Hip WOMAC (Western Ontario and McMaster Univer-
sities Osteoarthritis) was assessed in both cohorts, but knee WOMAC
was available only in TASOAC. Log binomial regression was used to
estimate the relative risk (RR) of presence of pain and of high cartilage
signal, and linear regressionwas used in the analysis of severity of pain.
Results: In the MCCS, 17% (24/143) of subjects had femoral and/or
acetabular BML. Presence of any acetabular BML (n¼20, 13%) was
associated with higher relative risk of hip pain [RR: 1.17, 95% CI: 1.03,
1.17]. Having a large femoral BML was associated with more severe hip
pain [mean difference in hip pain score: 40.6, 95% CI: 6.00, 75.3]. Hip
BML size was not associated with either hip or knee pain. In TASOAC,
28% (55/198) of subjects had a hip BML at either or both sites. In cross-
sectional analysis, presence of any large BML (n¼14, 8%) was associated
with higher risk of hip pain [RR 2.14, 95% CI: 1.34, 3.41] and having
a large acetabular BMLwas associatedwith greater severity of knee pain
[mean diff 2.11, 95% CI: 0.36, 3.84] and greater hip pain [mean diff 3.92,
95% CI: 1.63, 9.57]. Longitudinally, resolution of femoral BMLs was
associated with a decrease in hip [mean diff  2.75, 95% CI: 4.52,
0.99] and knee [mean diff 3.46, 95% CI: 5.91, 0.88] pain while
incident acetabular [mean diff +5.84, 95% CI: +3.63, +8.05] and femoral
[mean diff +0.98, 95% CI: +0.28, +1.78] BMLs were associated with
worsening hip pain. High cartilage signal was associated with hip BMLs
in each cohort [MCCS, RR: 1.70 95% CI: 1.41, 2.11; TASOAC, RR 1.79 95%
CI: 1.52, 1.92] but not with pain.
Conclusion: The consistent cross-sectional evidence from the MCCS
and TASOAC cohorts, which was conﬁrmed by longitudinal results from
the TASOAC cohort, suggests that large hip BMLs are associated with
both hip and knee pain. High cartilage signal was asymptomatic but
strongly associated with hip BMLs.
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ASSOCIATIONS OF FREQUENT PREDICTABLE AND UNPREDICTABLE
PAIN WITH FUNCTIONAL AND PSYCHOLOGICAL OUTCOMES
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Purpose: Studies have shown that greater pain severity is associated
with poorer functional and psychological outcomes among patients
with osteoarthritis (OA), but little is known about the impact of other
aspects of the pain experience. This study examined associations of the
frequency of predictable (e.g., occurs after a speciﬁc trigger) and
unpredictable (e.g., occurs without warning) pain with self-reported
functional outcomes and depressive symptoms among patients with
physician diagnoses of hip and/or knee OA.
Methods: Participants were n¼293 patients enrolled in a clinical trial of
a combined patient and provider intervention for managing OA at the
Durham Veterans Affairs Medical Center (mean age ¼ 61, SD¼9, 90%
male, 53% non-white - primarily African American). All measures were
from baseline assessments. The frequency of predictable and unpre-
dictable pain were assessed with two items from the Measure of
Intermittent and Constant Osteoarthritis Pain Index (ICOAP), both
categorized as frequent (often, very often) vs. infrequent (never, rarely,
sometimes). Physical function outcomes included the Western Ontario
and McMasters University Osteoarthritis Index (WOMAC) function
subscale and the Satisfaction with Physical Function Scale. Depressive
